Jay Horrow
About Jay Horrow
Jay Horrow is the Clinical Lead for Factor XI Outcome Trials at Bristol Myers Squibb and a Clinical Professor at the University of Pennsylvania with 30 years of experience in academic medicine.
Company
Jay Horrow is currently working at Bristol Myers Squibb in Princeton, New Jersey, United States, where he serves as Clinical Lead for Factor XI Outcome Trials. He also holds a position at the FDA as an Industry Representative on the Anesthesia & Analgesia Drug Products Advisory Committee. Additionally, he is a Clinical Professor of Anesthesiology & Critical Care Medicine at the University of Pennsylvania in Philadelphia, Pennsylvania.
Education and Expertise
Jay Horrow has a comprehensive educational background. He received his Doctor of Medicine (MD) from the University of Pennsylvania in 1977. Prior to that, he earned a Bachelor of Science in Electrical Engineering from Princeton University. Additionally, he obtained a Master of Science in Applied Statistics from Villanova University from 1998 to 2000. With formal graduate training in applied statistics, Horrow combines his clinical and analytical expertise in his professional roles.
Career in Drug Development
With 30 years in academic medicine and 20 years in clinical drug development, Jay Horrow has amassed extensive experience in the field. He has worked in various high-level positions including Vice President of Clinical Development at IBEX Technologies Corporation, Senior Director and Executive Director at AstraZeneca, and Executive Director at Merck. His roles have involved leadership in clinical development, particularly in cardiovascular and anesthesia & analgesia drug development.
Previous Roles in Academia
Jay Horrow served as Chair of Anesthesiology at Drexel University College of Medicine from 2005 to 2008. In his current academic role, he is a Clinical Professor at the University of Pennsylvania, where he focuses on Anesthesiology & Critical Care Medicine. His academic involvement underscores his dedication to both education and patient care.
Industry Representative at FDA
Jay Horrow holds a significant role as an Industry Representative on the Anesthesia & Analgesia Drug Products Advisory Committee at the FDA. This position leverages his expertise to provide industry perspectives on the development and regulation of anesthesia and analgesia drug products. His involvement with the FDA highlights his commitment to advancing healthcare through regulatory collaboration.